Abstract

All-trans retinoic acid (RA) was previously shown to regulate the growth of gastric cancer cells derived from the cell line SC-M1. This study was designed to investigate the effect of RA on the sensitivity of SC-M1 cells to lymphokine-activated killer (LAK) activity. RA at the concentration range of 0.001-10 microM was shown to induce SC-M1 cells to exhibit resistance to LAK activity in a dose-dependent manner. A kinetics study indicated that a significantly increased resistance was detected after 2 days of co-culturing SC-M1 cells with RA and reached a maximum after 6 days of culture. Similar results were obtained from two other cancer cell lines: promyelocytic leukaemia HL-60 and hepatic cancer Hep 3B. A binding assay demonstrated that the binding efficacy between target SC-M1 cells and effector LAK cells was not altered by RA. Flow cytometric analyses revealed that RA exhibited no effect on the expression of cell surface molecules, including HLA class I and class II antigens, intercellular adhesion molecule-1 and -2, and lymphocyte function antigen-3. Cell cycle analysis revealed that culture of SC-M1 cells with RA resulted in an increase in G0/G1 phase and a decrease in S phase, accompanied by a decrease in cyclin A and cyclin B1 mRNA as determined by Northern blot analysis. Additionally, RA was shown to enhance the expression of retinoic acid receptor alpha (RAR alpha) in SC-M1 cells, and to have no effect on the expression of RARbeta or RARgamma. Taken together, these results indicate that RA can significantly increase gastric cancer cells SC-M1 to resist LAK cytotoxicity by means of a cytostatic effect through a mechanism relating to cell cycle regulation. The prevailing ideas, such as a decrease in effector to target cell binding, a reduced MHC class I antigen expression or an altered RARbeta expression, are not involved.

Highlights

  • SC-Mi cells with retinoic acid (RA) resulted in an increase in GJG, phase and a decrease in S phase, accompanied by a decrease in cyclin A and cyclin Bi

  • SC-Mi cells with RA resulted in an increase in GJG, phase and a decrease in S phase, accompanied by a decrease in cyclin A and cyclin Bi mRNA as determined by Northern blot analysis

  • RA was shown to enhance the expression of retinoic acid receptor a (RARa) in SC-Mi cells, and to have no effect on the expression of RARfi or RARy

Read more

Summary

Methods

Target cellsThree cancer cell lines, including gastric cancer SC-MI, promyelocytic leukaemia HL-60 and hepatic cancer Hep 3B, were used as target cells in the cytotoxicity assay. Tumour cells were maintained in RPMI-1640 medium with 10% fetal calf serum (FCS) (Gibco, Grand Island, NY, USA). Peripheral blood mononuclear cells (PBMCs) were obtained from normal healthy volunteers and incubated at 37°C in complete medium containing 3000 IU ml-' IL-2, under a moist atmosphere with 5% carbon dioxide in culture flasks at a cell concentration of 2-3 x 106 ml'. Complete medium contained RPMI-1640 with 10% FCS, 0.3 mg ml-1 L-glutamine, 100 gg ml-' streptomycin and 100 U ml-' penicillin. Activated killer cells were harvested after culture for 4 days and washed twice with RPMI- 1640. The viable cells were counted and resuspended in RPMI-1640 containing 10% FCS for the standard 4-h 5'Cr-release assay (Chao et al, 1990, 1995a), and for surface marker studies with flow cytometry (Chao et al, 1995b)

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call